LMSunshine
2022-08-09

Novavax is a πŸ’”πŸ’”πŸ’”-Elsa sings, "Let it go,let it go, can't hold it back anymore 🎈🎈🎈" $Novavax(NVAX)$

NVAX has been a heartache to a lot of investors πŸ’”πŸ’”πŸ’” It tumbled from its all-time high of USD 319.93 on Feb 8, 2021, which is a about an 88% CRASH 😱😱😱

NVAX has repeatedly pushed back production forecasts & has struggled to access raw materials & equipment needed to make its vaccine πŸ—“πŸ­ πŸ’‰

Till now…NVAX still hasn’t obtained full FDA approval for its vaccine ❌ It was only granted Emergency Use Authorisation for over 18 year-olds in early June & WHO has not recognised their vaccine use for below 18 years of age ❌

Now, it has even:

(1) posted a 3rd quarter loss of 6.53 per share, with revenues slowing 37.6% from last year to just 185.9 million;

(2) halved its 2022 sales forecast to between $2 billion and $2.3 billion; &

(3) warned that it does not expect to sell any more of its Covid vaccines in the US this year.

πŸ€”πŸ’­: My Thoughts: This earnings is too BIG a miss & it sure shows how the management of NVAX over-promises & under-delivers. Their historical trend shows this as well (see photo). A successful company requires great leaders & direction-this is something that NVAX doesn’t have & will not be able to compete with Pfizer-BioNTech or Moderna. I don’t have a target price for NVAX as I really can't see it as a profitable company…Sorry 🐯🐯🐯

As usual-πŸ€”πŸ’­ Consider POV & Actions of investors + πŸ‘©πŸ»β€πŸ’»πŸ‘¨πŸ»β€πŸ’» Research + πŸ—‘FOMO & Greed = Investing Wisely πŸ€“πŸ€— + Accumulating Wealth πŸ’΅πŸ’°

@TigerStars@CaptainTiger@MillionaireTiger

NVAX: What's your target price after earnings miss?
【KEY POINTS】 1. Novavax stock plunged 31% after the company provided its Q2 update. 2. The vaccine maker badly missed revenue and earnings estimates and slashed its full-year revenue guidance. 【Topic】What's your thoughts on NVAX earnings? Target price after earnings miss?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
1